Nabumetone Tablet, Film Coated
Product Images NDC 43063-972

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 43063-972). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063972 Label (43063972)

This medication is NABUMETONE, which contains 500mg of the drug per oval tablet, presented in a box of 20 tablets. It is advised to take the tablet with food and the specific dosage information can be found in the package insert. ALCOHOL OR ALCOHOLIC BEVERAGES SHOULD NOT be consumed while using this medication. It is important to keep it out of children's reach. If any side effects occur, it should be reported to the FDA or your doctor. The manufacturer of the medication is PD Pharmaceuticals, and the lot number for the box is C22A09, with an expiration date of June 203.*

FDA Label Image

Structure (Nabumetone 1)

FDA Label Image

6mna (Nabumetone 2)

FDA Label Image

Figure (Nabumetone 3)

This is a graph showing the active metabolite (MNA) plasma concentrations at steady state following once-daily dosing of nabumetone. The study was conducted with two groups of participants who were given either 1000 mg or 2000 mg of nabumetone, and the plasma concentrations of MNA were measured at different times over a 24-hour period. The graph shows that higher doses of nabumetone resulted in higher plasma concentrations of MNA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.